TapImmune Creates Scientific Advisory Board to Support Clinical Development of Multi-Antigen Cell Therapy Platform

Welcomes Renowned Thought Leaders Dr. Malcolm Brenner, Dr. Helen Heslop, and Dr. Cliona Rooney JACKSONVILLE, Fla., May 16, 2018 -- (Healthcare Sales & Marketing Network) -- TapImmune Inc. (NASDAQ: TPIV), a clinical-stage immuno-oncology company, today ... Biopharmaceuticals, Oncology, Personnel TapImmune, Marker Therapeutics, immunotherapy
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news